Quality Improvement Success Stories are published by the American Diabetes Association in collaboration with the American College of Physicians and the National Diabetes Education Program. This series is intended to highlight best practices and strategies from programs and clinics that have successfully improved the quality of care for people with diabetes or related conditions. Each article in the series is reviewed and follows a standard format developed by the editors of .
View Article and Find Full Text PDFTransl Pediatr
December 2024
Background: Aggressive behavior in adolescent patients is a common phenomenon in clinical treatment and nursing care. The objective of this study was to conduct an assessment of the prevailing patterns and determinants of aggressive behavior among adolescents with mental disorders, with the intent to offer valuable insights for enhancing clinical intervention and nursing practices.
Methods: Adolescent patients with mental disorders admitted to the psychiatric department of Suzhou Guangji Hospital from January 1, 2022, to June 30, 2024 were included.
Background: Research suggest that mind-body movement programs have beneficial effects on cognitive outcomes for older adults with cognitive decline. However, few studies have directly compared specific approaches to mind-body movement or studied the impact of remote program delivery.
Methods: In a 3-arm randomized controlled trial (RCT) for older adults with cognitive impairment, we are comparing a multidomain mind-body program that emphasizes movement, body awareness, personal meaningfulness, and social connection, and a traditional Chinese mind-body exercise (Tai Chi) to a health and wellness education control condition.
Int J Parasitol Parasites Wildl
April 2025
Species description based on the pictorial keys of morphological characters of female tick parasitizing wild Taiwan cobra snake () was firstly described in Taiwan. Molecular analysis based on the 16S mitochondrial gene sequences was performed by comparing eight ticks from Taiwan with other species documented in GenBank. In addition, two and two species were used as outgroups.
View Article and Find Full Text PDFBackground: This study evaluates the efficacy and safety of sitagliptin versus gliclazide, combined with metformin, in treatment-naive patients with type 2 diabetes mellitus (T2DM) and glucotoxicity.
Methods: In this single-center, randomized, controlled noninferiority trial, 129 treatment-naive patients with T2DM with glucotoxicity (fasting plasma glucose [FPG] ≥ 200 mg/dL and glycated hemoglobin ≥ 9.0%) were randomized to receive sitagliptin plus metformin (n = 66) or gliclazide plus metformin (n = 63) for 12 weeks.